EMEA-001304-PIP02-13-M03

Key facts

Invented name
Ocaliva
Active substance
Obeticholic acid (6 alpha-ethylchenodeoxycholic acid)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0213/2017
PIP number
EMEA-001304-PIP02-13-M03
Pharmaceutical form(s)
  • Coated tablet
  • Tablet
Condition(s) / indication(s)
  • Treatment of biliary atresia
  • Treatment of primary biliary cirrhosis
Route(s) of administration
Oral use
Contact for public enquiries
Intercept Pharma Ltd.
United Kingdom
Tel. +1 6195417227
E-mail: reginfo@interceptpharma.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating